Clinical Trials › NCT05201638
Active, Not RecruitingPhase 3
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
Sponsored by Immunic AG
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 1100
Target enrollment
1
U.S. states
Jan 2022
Start date
Oct 2033
Expected completion
Interventions / Treatments
IMU-838 tabletsPlacebo matching IMU-838 tablets
Conditions studied
Multiple Sclerosis, Relapsing-Remitting
Where this trial is running (2 sites)
Florida2 sites
Altamonte Springs · Coral Springs
Participating MS centers on MS Buddy (1)
Neurology of Central Florida
Altamonte Springs, FL
Altamonte Springs, FL
MS centers in Florida
Compare treatment centers near a trial site by center type, providers and trials.
View Florida centersMore Phase 3 trials
Browse all Phase 3 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.